Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Facility inspections increase

This article was originally published in The Gray Sheet

Executive Summary

FDA's device center exceeded facility inspection goals last year by at least 20%, according to CDRH's 1annual report for fiscal 2006. The agency conducted 1,299 domestic inspections of device firms (1,066 planned), as well as 207 foreign inspections (168 planned) and 336 bioresearch monitoring (BIMO) inspections (278 planned), the report states. The increased number of inspections is part of the center's enhanced postmarket oversight to ensure the safety and effectiveness of products, CDRH Director Dan Schultz says. The document notes that CDRH also exceeded by 15% its 2006 goal of obtaining a 71% participation rate from the 350 health care facilities participating in the Medical Product Surveillance Network (MedSun) (2"The Gray Sheet" July 25, 2006, p. 26)
Advertisement
Advertisement

Related Content

Advertisement
UsernamePublicRestriction

Register

MT025254

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel